Forbion Fund IV
Share
N°01 / About
About Forbion Fund IV
Innovative biotech and therapeutics addressing high-need indications, built either from scratch (NewCo model) or around proven management teams and in-licensed assets Geography: Primarily Europe and North America.
Investor Signals Profile
active
Sweet Spot
Pre-clinical or early clinical biotech founders needing build support
3 signals on Forbion Fund IV
1 bullish · 2 pitch do's, each with its source. From €9/month, cancel anytime.
Backers+2 more LPs in LP Radar
Known LPs
KfW CapitalPublic / State institution
Eli Lilly and CompanyCorporate / Strategic
Kauffman FoundationFoundation / Endowment